Josef Vuch
University of Trieste
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Josef Vuch.
International Journal of Developmental Neuroscience | 2012
Annalisa Marcuzzi; Valentina Zanin; Elisa Piscianz; Paola Maura Tricarico; Josef Vuch; Martina Girardelli; Lorenzo Monasta; Anna Monica Bianco; Sergio Crovella
Mevalonic aciduria (MA), the most severe form of mevalonate kinase deficiency (MKD), is still an orphan drug disease and the pathogenetic mechanisms underlying neuronal dysfunction is still poorly understood. In our study we have investigated the apoptotic mechanism mediated by the exposure of the cultured neuroblastoma cell line, SH‐SY5Y, to lovastatin in absence or in presence of the isoprenoid, geranylgeraniol, with the aim of unraveling the pathogenesis of MA. Lovastatin, blocks the mevalonate pathway inhibiting the 3‐hydroxy‐3‐methylglutaryl‐CoA reductase (HMG‐CR), an enzyme of the mevalonate pathway upstream the mevalonate kinase enzyme, reproducing biochemical features similar to those found in MKD.
BioMed Research International | 2013
Fulvio Celsi; Eulalia Catamo; Giulio Kleiner; Paola Maura Tricarico; Josef Vuch; Sergio Crovella
In recent years, a number of different mechanisms regulating gene expressions, either in normal or in pathological conditions, have been discovered. This review aims to highlight some of the regulatory pathways involved during the HIV-1 infection and disease progression, focusing on the novel discovered microRNAs (miRNAs) and their relation with immune systems agents. Human leukocyte antigen (HLA) family of proteins plays a key role because it is a crucial modulator of the immune response; here we will examine recent findings, centering especially on HLA-C and -G, novel players lately discovered to engage in modulation of immune system. We hope to provide novel perspectives useful to find out original therapeutic roads against HIV-1 infection and AIDS progression.
Genomics | 2013
Anna Monica Bianco; Annalisa Marcuzzi; Valentina Zanin; Martina Girardelli; Josef Vuch; Sergio Crovella
The knowledge of the human genome is in continuous progression: a large number of databases have been developed to make meaningful connections among worldwide scientific discoveries. This paper reviews bioinformatics resources and database tools specialized in disseminating information regarding genetic disorders. The databases described are useful for managing sample sequences, gene expression and post-transcriptional regulation. In relation to data sets available from genome-wide association studies, we describe databases that could be the starting point for developing studies in the field of complex diseases, particularly those in which the causal genes are difficult to identify.
Pediatric Rheumatology | 2014
Carlo De Pieri; Josef Vuch; Eleonora De Martino; Anna Monica Bianco; Luca Ronfani; Emmanouil Athanasakis; Barbara Bortot; Sergio Crovella; Andrea Taddio; Giovanni Maria Severini; Alberto Tommasini
BackgroundPeriodic fever syndromes (PFS) are an emerging group of autoinflammatory disorders. Clinical overlap exists and multiple genetic analyses may be needed to assist diagnosis. We evaluated the diagnostic value of a 5-gene sequencing panel (5GP) in patients with undiagnosed PFS.MethodsSimultaneous double strand Sanger sequencing of MEFV, MVK, TNFRSF1A, NLRP3, NLRP12 genes was performed in 42 patients with unexplained PFS. Clinical features were correlated with genetic results.ResultsNone of 42 patients analyzed displayed a causative genotype. However, single or multiple genetic variants of uncertain significance were detected in 24 subjects. Only in 5 subjects a definite diagnosis was made by taking into account both genetic and clinical data (2 TRAPS syndrome; 2 FMF; 1 FCAS). Statistical analysis showed that patients carrying genetic variants in one or more of the five selected genes displayed a significantly lower response to glucocorticoids compared with subjects who had completely negative genetic results.ConclusionsThe sequencing of multiple genes is of little help in the diagnostics of PFS and can often lead to results of uncertain interpretation, thus the clinically driven sequencing of single genes should remain the recommended approach. However, the presence of single or multiple genetic variants of uncertain significance, even if not allowing any specific diagnosis, correlated with a poorer response to glucocorticoids, possibly indicating a multifactorial subgroup of PFS with differential response to pharmacological treatment.
World Journal of Clinical Pediatrics | 2015
Serena Pastore; Josef Vuch; Anna Monica Bianco; Andrea Taddio; Alberto Tommasini
Over the centuries the idea of recurrent fevers has mainly been associated with malaria, but many other fevers, such as typhoid and diphtheria were cause for concern. It is only in recent times, with the more severe forms of fever from infectious origin becoming less frequent or a cause for worry that we started noticing recurrent fevers without any clear infectious cause, being described as having a pathogenesis of autoinflammatory nature. The use of molecular examinations in many cases can allow a diagnosis where the cause is monogenic. In other cases, however the pathogenesis is likely to be multifactorial and the diagnostic-therapeutic approach is strictly clinical. The old fever tree paradigm developed to describe fevers caused by malaria has been revisited here to describe todays periodic fevers from the periodic fever adenitis pharyngitis aphthae syndrome to the more rare autoinflammatory diseases. This model may allow us to place cases that are yet to be identified which are likely to be of multifactorial origin.
International Journal of Molecular Sciences | 2014
Martina Girardelli; Josef Vuch; Alberto Tommasini; Sergio Crovella; Anna Monica Bianco
Deregulated immune response to gut microflora in genetically predisposed individuals is typical for inflammatory bowel diseases. It is reasonable to assume that genetic association with the disease will be more pronounced in subjects with early onset than adult onset. The nucleotide-binding oligomerization domain containing-2 gene, commonly involved in multifactorial risk of Crohn’s disease, and interleukin 10 receptor genes, associated with rare forms of early onset inflammatory bowel diseases, were sequenced in an early onset patient. We identified a novel variant in the NOD2 gene (c.2857A > G p.K953E) and two already described missense variants in the IL10RA gene (S159G and G351R). The new NOD2 missense variant was examined in silico with two online bioinformatics tools to predict the potentially deleterious effects of the mutation. Although cumulative effect of these variations in the early onset of the disease can be only hypothesized, we demonstrated that family information and in silico studies can be used to predict association with the disease.
Alimentary Pharmacology & Therapeutics | 2012
Anna Monica Bianco; Josef Vuch; Martina Girardelli; Valentina Zanin; Annalisa Marcuzzi; Sergio Crovella
‘good’ and ‘very good’ satisfactory relief of symptoms in the treatment period with enriched artichokes was 12 out of 20. The number was 16 if ‘moderate’ relief of symptoms was also included. The overall treatment-phase preference was assessed by patients at the end of the study by responding to the following question ‘Which treatment period (period 1, period 2, or no preference) did you prefer in the management of your constipation concerning the stool consistency and/or frequency?’ (Treatment 1 was better than treatment 2; treatment 2 was better than treatment 1; treatment 1 was equal to treatment 2). Finally, a modified intention-to-treat (ITT) analysis instead of a true ITT was used. Recently, the ‘modified ITT’ analysis has become popular as an alternative to a ‘strict ITT’ analysis. This design allows some exclusions from the ITT population, if these exclusions can be justified as unlikely to bias the results. In this framework, the authors defined their analysis as a ‘modified ITT’ one, since the group of five patients who were excluded from the study never started the treatment. Therefore, their exclusion neither affected the results of the study nor introduced a potential bias in their interpretation.
Inflammation Research | 2012
Valentina Zanin; Annalisa Marcuzzi; Elisa Piscianz; Josef Vuch; Anna Monica Bianco; Lorenzo Monasta; Giuliana Decorti; Sergio Crovella
Molecular Medicine Reports | 2016
Annalisa Marcuzzi; Diego Vozzi; Martina Girardelli; Paola Maura Tricarico; Alessandra Knowles; Sergio Crovella; Josef Vuch; Alberto Tommasini; Elisa Piscianz; Anna Monica Bianco
Gene | 2018
Martina Girardelli; Federica Basaldella; Sara Della Paolera; Josef Vuch; Alberto Tommasini; Stefano Martelossi; Sergio Crovella; Anna Monica Bianco